Tissue Engineering Inc is categorized under Commercial Biotechnical Research in Boston, MA and active since 1991.
Tissue Engineering Inc was established in 1991, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Eugene Bell at the company’s single location by writing to 7 Elkins St, Boston, Massachusetts MA 02127 or by phoning (617) 268-1616. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Tissue Engineering Inc |
| Contact Person: | Eugene Bell |
| Address: | 7 Elkins St, Boston, Massachusetts 02127 |
| Phone Number: | (617) 268-1616 |
| Website Address: | teibio.com |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 1991 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
Tissue Engineering Inc was started in 1991 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Eugene Bell for inquiries that concern Tissue Engineering Inc by calling the company number (617) 268-1616, as your correspondence is most welcome. Additionally, the physical location of the single location of Tissue Engineering Inc can be found at the coordinates 42.339351,-71.035778 as well as the street address 7 Elkins St in Boston, Massachusetts 02127.
For its online presence, you may visit Tissue Engineering Inc’s website at teibio.com and engage with its social media outlets through on Twitter and on Facebook.